203 related articles for article (PubMed ID: 11809723)
1. Different substitutions at residue D218 of the X-linked transcription factor GATA1 lead to altered clinical severity of macrothrombocytopenia and anemia and are associated with variable skewed X inactivation.
Freson K; Matthijs G; Thys C; Mariën P; Hoylaerts MF; Vermylen J; Van Geet C
Hum Mol Genet; 2002 Jan; 11(2):147-52. PubMed ID: 11809723
[TBL] [Abstract][Full Text] [Related]
2. Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation.
Freson K; Devriendt K; Matthijs G; Van Hoof A; De Vos R; Thys C; Minner K; Hoylaerts MF; Vermylen J; Van Geet C
Blood; 2001 Jul; 98(1):85-92. PubMed ID: 11418466
[TBL] [Abstract][Full Text] [Related]
3. Molecular cloning and characterization of the GATA1 cofactor human FOG1 and assessment of its binding to GATA1 proteins carrying D218 substitutions.
Freson K; Thys C; Wittewrongel C; Vermylen J; Hoylaerts MF; Van Geet C
Hum Genet; 2003 Jan; 112(1):42-9. PubMed ID: 12483298
[TBL] [Abstract][Full Text] [Related]
4. Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1.
Nichols KE; Crispino JD; Poncz M; White JG; Orkin SH; Maris JM; Weiss MJ
Nat Genet; 2000 Mar; 24(3):266-70. PubMed ID: 10700180
[TBL] [Abstract][Full Text] [Related]
5. Dyserythropoietic anemia and thrombocytopenia due to a novel mutation in GATA-1.
Del Vecchio GC; Giordani L; De Santis A; De Mattia D
Acta Haematol; 2005; 114(2):113-6. PubMed ID: 16103636
[TBL] [Abstract][Full Text] [Related]
6. Effects of the R216Q mutation of GATA-1 on erythropoiesis and megakaryocytopoiesis.
Balduini CL; Pecci A; Loffredo G; Izzo P; Noris P; Grosso M; Bergamaschi G; Rosti V; Magrini U; Ceresa IF; Conti V; Poggi V; Savoia A
Thromb Haemost; 2004 Jan; 91(1):129-40. PubMed ID: 14691578
[TBL] [Abstract][Full Text] [Related]
7. X-linked thrombocytopenia caused by a novel mutation of GATA-1.
Mehaffey MG; Newton AL; Gandhi MJ; Crossley M; Drachman JG
Blood; 2001 Nov; 98(9):2681-8. PubMed ID: 11675338
[TBL] [Abstract][Full Text] [Related]
8. X-linked thrombocytopenia with thalassemia from a mutation in the amino finger of GATA-1 affecting DNA binding rather than FOG-1 interaction.
Yu C; Niakan KK; Matsushita M; Stamatoyannopoulos G; Orkin SH; Raskind WH
Blood; 2002 Sep; 100(6):2040-5. PubMed ID: 12200364
[TBL] [Abstract][Full Text] [Related]
9. Selective impairment of platelet activation to collagen in the absence of GATA1.
Hughan SC; Senis Y; Best D; Thomas A; Frampton J; Vyas P; Watson SP
Blood; 2005 Jun; 105(11):4369-76. PubMed ID: 15701726
[TBL] [Abstract][Full Text] [Related]
10. Differential requirements for the activation domain and FOG-interaction surface of GATA-1 in megakaryocyte gene expression and development.
Muntean AG; Crispino JD
Blood; 2005 Aug; 106(4):1223-31. PubMed ID: 15860665
[TBL] [Abstract][Full Text] [Related]
11. A Novel GATA1 Variant in the C-Terminal Zinc Finger Compared with the Platelet Phenotype of Patients with A Likely Pathogenic Variant in the N-Terminal Zinc Finger.
Bastida JM; Malvestiti S; Boeckelmann D; Palma-Barqueros V; Wolter M; Lozano ML; Glonnegger H; Benito R; Zaninetti C; Sobotta F; Schilling FH; Morgan NV; Freson K; Rivera J; Zieger B
Cells; 2022 Oct; 11(20):. PubMed ID: 36291092
[TBL] [Abstract][Full Text] [Related]
12. Mature erythrocyte membrane homeostasis is compromised by loss of the GATA1-FOG1 interaction.
Hasegawa A; Shimizu R; Mohandas N; Yamamoto M
Blood; 2012 Mar; 119(11):2615-23. PubMed ID: 22279059
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome of hemizygous and heterozygous carriers of a germline GATA1 (G208R) mutation.
Dührsen U; Kratz CP; Flotho C; Lauenstein T; Bommer M; König E; Brittinger G; Heimpel H
Ann Hematol; 2011 Mar; 90(3):301-6. PubMed ID: 20922527
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic and genetic heterogeneity arising from a novel substitution at amino acid position Val205 in GATA1 related X-linked thrombocytopenia with dyserythropoietic anemia.
Jamwal M; Aggarwal A; Sharma P; Bansal D; Maitra A; Das R
Blood Cells Mol Dis; 2020 Mar; 81():102391. PubMed ID: 31865264
[No Abstract] [Full Text] [Related]
15. X-linked gray platelet syndrome due to a GATA1 Arg216Gln mutation.
Tubman VN; Levine JE; Campagna DR; Monahan-Earley R; Dvorak AM; Neufeld EJ; Fleming MD
Blood; 2007 Apr; 109(8):3297-9. PubMed ID: 17209061
[TBL] [Abstract][Full Text] [Related]
16. GATA-factor dependence of the multitype zinc-finger protein FOG-1 for its essential role in megakaryopoiesis.
Chang AN; Cantor AB; Fujiwara Y; Lodish MB; Droho S; Crispino JD; Orkin SH
Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9237-42. PubMed ID: 12077323
[TBL] [Abstract][Full Text] [Related]
17. GATA transcription factors in hematologic disease.
Cantor AB
Int J Hematol; 2005 Jun; 81(5):378-84. PubMed ID: 16158817
[TBL] [Abstract][Full Text] [Related]
18. Platelet pathology in sex-linked GATA-1 dyserythropoietic macrothrombocytopenia I ultrastructure.
White JG; Nichols WL; Steensma DP
Platelets; 2007 Jun; 18(4):273-83. PubMed ID: 17538848
[TBL] [Abstract][Full Text] [Related]
19. Transgenic rescue of GATA-1-deficient mice with GATA-1 lacking a FOG-1 association site phenocopies patients with X-linked thrombocytopenia.
Shimizu R; Ohneda K; Engel JD; Trainor CD; Yamamoto M
Blood; 2004 Apr; 103(7):2560-7. PubMed ID: 14656885
[TBL] [Abstract][Full Text] [Related]
20. Platelet pathology in sex-linked GATA-1 dyserythropoietic macrothrombocytopenia II. Cytochemistry.
White JG; Nichols WL; Steensma DP
Platelets; 2007 Sep; 18(6):436-50. PubMed ID: 17763153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
